4.6 Article

Preliminary Study of a 1,5-Benzodiazepine-Derivative Labelled with Indium-111 for CCK-2 Receptor Targeting

Related references

Note: Only part of the references are listed.
Article Medicine, Research & Experimental

[99mTc]Tc-DGA1, a Promising CCK2R-Antagonist-Based Tracer for Tumor Diagnosis with Single-Photon Emission Computed Tomography

Aikaterini Kaloudi et al.

MOLECULAR PHARMACEUTICS (2020)

Review Biochemistry & Molecular Biology

Development of Targeted Alpha Particle Therapy for Solid Tumors

Narges K. Tafreshi et al.

MOLECULES (2019)

Article Radiology, Nuclear Medicine & Medical Imaging

In vivo imaging characterization and anticancer efficacy of a novel HER2 affibody and pemetrexed conjugate in lung cancer model

Honglei Jiao et al.

NUCLEAR MEDICINE AND BIOLOGY (2019)

Review Radiology, Nuclear Medicine & Medical Imaging

Radiolabeled peptides: current and new perspectives

Marta Opalinska et al.

QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)

Article Radiology, Nuclear Medicine & Medical Imaging

99mTc-labeled gastrins of varying peptide chain length: Distinct impact of NEP/ACE-inhibition on stability and tumor uptake in mice

Aikaterini Kaloudi et al.

NUCLEAR MEDICINE AND BIOLOGY (2016)

Article Radiology, Nuclear Medicine & Medical Imaging

Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue

Joachim Pfister et al.

EJNMMI RESEARCH (2015)

Article Radiology, Nuclear Medicine & Medical Imaging

Evaluation of a Nonpeptidic Ligand for Imaging of Cholecystokinin 2 Receptor-Expressing Cancers

Charity Wayua et al.

JOURNAL OF NUCLEAR MEDICINE (2015)

Article Pharmacology & Pharmacy

The gastrin/cholecystokinin-B receptor on prostate cells - A novel target for bifunctional prostate cancer imaging

Alexander Sturzu et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2014)

Article Medicine, Research & Experimental

Evaluation of a Cholecystokinin 2 Receptor-Targeted Near-Infrared Dye for Fluorescence-Guided Surgery of Cancer

Charity Wayua et al.

MOLECULAR PHARMACEUTICS (2014)

Review Radiology, Nuclear Medicine & Medical Imaging

Radiopharmaceutical development of radiolabelled peptides

Melpomeni Fani et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2012)

Review Biochemistry & Molecular Biology

Radiolabeled CCK/gastrin peptides for imaging and therapy of CCK2 receptor-expressing tumors

Susan Roosenburg et al.

AMINO ACIDS (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparison of the binding and internalization properties of 12 DOTA-coupled and 111In-labelled CCK2/gastrin receptor binding peptides: a collaborative project under COST Action BM0607

Luigi Aloj et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)

Article Radiology, Nuclear Medicine & Medical Imaging

Comparative biodistribution of 12 111In-labelled gastrin/CCK2 receptor-targeting peptides

Peter Laverman et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)

Article Biochemistry & Molecular Biology

Development of a new radioligand for cholecystokinin receptor subtype 2 scintigraphy: From molecular modeling to in vivo evaluation

Severine Brillouet et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2010)

Review Biochemical Research Methods

The synthesis and chelation chemistry of DOTA-peptide conjugates

Luis M. De Leon-Rodriguez et al.

BIOCONJUGATE CHEMISTRY (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours

Stephan Good et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)

Article Radiology, Nuclear Medicine & Medical Imaging

Targeting of a CCK2 receptor splice variant with 111In-labelled cholecystokinin-8 (CCK8) and 111In-labelled minigastrin

Peter Laverman et al.

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)